Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,186 | 37,744 | 45,396 | 58,180 | 11,674 |
| Marketable Securities | 45,975 | 26,524 | 21,524 | 23 | 24 |
| Receivables | N/A | N/A | N/A | N/A | 141 |
| Other current assets | 0 | 0 | 0 | 1,000 | 0 |
| TOTAL | $62,688 | $65,842 | $68,835 | $59,523 | $11,839 |
| Non-Current Assets | |||||
| PPE Net | 357 | 234 | 243 | 148 | 152 |
| Other Non-Current Assets | 1,308 | 1,364 | 1,440 | 452 | 485 |
| TOTAL | $1,665 | $1,598 | $1,683 | $600 | $637 |
| Total Assets | $64,353 | $67,440 | $70,518 | $60,123 | $12,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,336 | 481 | 472 | 2,083 | 93 |
| Accrued Expenses | 555 | 637 | 1,615 | 1,956 | 715 |
| Other current liabilities | 653 | 451 | N/A | 523 | 438 |
| TOTAL | $2,650 | $1,630 | $2,159 | $4,631 | $1,316 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 237 | 298 | 320 | 328 | 358 |
| TOTAL | $237 | $298 | $320 | $328 | $358 |
| Total Liabilities | $2,887 | $1,928 | $2,479 | $4,959 | $1,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,851 | 2,850 | 2,849 | 2,674 | 11,594 |
| Retained earnings | -36,173 | -31,137 | -28,169 | -25,399 | -23,695 |
| TOTAL | $61,466 | $65,512 | $68,039 | $55,164 | $10,802 |
| Total Liabilities And Equity | $64,353 | $67,440 | $70,518 | $60,123 | $12,476 |